Patient Selection and Pre-SVF Treatment Evaluations
Deaths, deaths, CKD, chronic kidney disease
INTRACEREBRAL HEMORRHAGE, RENAL FAILURE, ADVERSE EVENTS, COMPLICATION
Patients identified at community health centers were screened by the staff nephrologist; and confirmatory laboratory studies of serum and urine were performed. Eighteen male agricultural workers, 29-55 years of age (45.2 ± 8.5 mean ± SD years), were recruited at UNAN-Leon with a diagnosis of CKDu and no other co-morbidities. Characteristics of these patients upon presentation are summarized in SVF-treated subject characteristics and safety.All subjects were male. Deaths occurred in two stage 5 patients, who died of deterioration of their renal failure, and one stage 5 patient, who died of a complication of intracerebral hemorrhage. No deaths were attributable to study invasive procedures or SVF cell infusion. Abbreviations: CKD, chronic kidney disease, SAE, serious adverse events; SVF, stromal vascular fraction.